Weekly Livestock-Equine News: September 8, 2025

Pork producer pushes certifiers to reject gene-editing

duBreton, an organic pork producer based in Quebec, Canada, is calling on animal welfare and food certification bodies in Canada and the U.S. to take a clear stance against gene-edited pork. Earlier this summer, the company called for full transparency in response to the recent approval of the gene edited PRRS-resistant pig (PRP) by the U.S. FDA. duBreton operates four processing plants, including one in the United States.

FDA approves generic gamithromycin injectable for bovine respiratory disease

The FDA approved Gamrozyne (gamithromycin) injectable solution from Bimeda Animal Health Ltd. for the treatment of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis in beef and non-lactating dairy cattle. Gamrozyne is also indicated for the control of respiratory disease in beef and non-lactating dairy cattle at high risk of developing BRD. Gamrozyne is the first FDA-approved generic version of Zactran injectable solution.

Kemin acquisition expands animal vaccine business

Des Moines, Iowa-based Kemin Industries acquired Hennessy Research Associates, which specializes in the research and development of vaccines for infectious diseases of animals. Hennessy will specialize in veterinary biologicals as a contract research organization, contract development and manufacturing organization and contract manufacturer.

APHIS calls for 72-hour isolation period before poultry sent for slaughter

The U.S. Department of Agriculture’s Animal & Plant Health Inspection Service (APHIS) announced an update to its highly pathogenic avian influenza (HPAI) surveillance guidelines for poultry, effective Aug. 26, 2025. The agency now recommends a 72-hour pre-movement isolation period before birds are loaded for slaughter, during which no birds should be moved on or off the premises, and only essential personnel should enter. In addition, testing guidelines were updated.

Shreiber School is NJ’s first school of veterinary medicine

New Jersey launched its first school of veterinary medicine – the Shreiber School of Veterinary Medicine at Rowan University in Gloucester County – with the first day of classes on Aug. 28 for a cohort of 75 students. Tuition for the program at Rowan, a public research university, will cost first-year, in-state students $37,500 a year. Out-of-state students will pay $58,500 a year.

Boehringer Ingelheim swine vaccine offers advanced protection against PCV2

Boehringer Ingelheim announced the U.S. launch of INGELVAC CIRCOFLEX® AD, which the company says is the first vaccine to combine PCV2a and PCV2d antigens in a single dose for optimized herd health. The vaccine offers immunity after just two weeks and at least six months of protection. Porcine circovirus associated disease (PCVAD) is caused by the PCV2 virus and can lead to severe weight loss, difficulty breathing and diarrhea.